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INTRODUCTION 1-3 
          The ability to provide timely, accurate and reliable data is central to 
the role of analytical chemists and is especially true in the discovery, 
development and manufacture of pharmaceuticals. Current good 
manufacturing procedure (cGMP) recommends that every pharmaceutical 
company have a quality control unit to approve or reject all procedures or 
specifications that affect the identity, strength, quality and purity of every 
drug product based on test for drug characteristics such as potency and 
dissolution. 
          Some of the key components in quality control which have a great 
impact on the quality control of the final product are: 
1. Scale up 
2. Raw material inspection 
3. In process inspection 
4. Product testing 
5. Stability testing 
Analytical Techniques 
          The following analytical techniques have been employed for 
estimation of different components in formulation. 
1. Titrimetric and Gravimetric method. 
2. Colorimetric and UV spectrophotometric method. 
3. Flame photometry and atomic absorption spectrometry 
Introduction 
 2
4. Mass spectroscopy 
5. Chromatographic methods which includes; 
¾  Paper Chromatography 
¾ on-exchange chromatography. 
¾   High Performance Thin Layer Chromatography(HPTLC) 
¾ High Performance Liquid Chromatography(HPLC). 
¾    Gas Chromatography (GC). 
 5.   Hybrid Techniques       
 Combination of the above chromatographic techniques produce 
‘hybrid’ or ‘hyphenated’ techniques. Several examples are in popular use 
today and new hybrid techniques are under development. For example 
¾ GC-MS 
¾ LC-MS 
¾ HPLC/ ESI-MS 
¾ LC-DAD 
¾ CE-MS 
¾ CE-UV 
 
ANALYTICAL METHOD VALIDATION 
           Analytical data are used to screen potential drug candidates, aid in 
development of drug synthesis, support formulation studies, monitor the 
stability of bulk pharmaceuticals and formulated products, and test final 
products for release. The quality of analytical data is a key factor in the 
success of a drug development program. The process of method 
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development and validation has a direct impact on the quality of these 
data.  
Analytical Method Development is required for: 
¾ Herbal Products 
¾ New process and reactions 
¾ New molecules 
¾ Active Ingredients(Macro analysis) 
¾ Residues(Micro analysis) 
¾ Impurity Profiling 
¾ Component of interest in different matrices. 
Analytical Methodology provides to an analyst: 
¾ The required data for a given analytical problem. 
¾ The required sensitivity. 
¾ The required accuracy. 
¾ The required range of analysis. 
¾ The required precision. 
    Method Validation is the process of proving that an analytical method is 
acceptable for its intended purpose. Method Validation is a continuous 
process. The goal is to ensure confidence in the analytical data throughout 
product development. The steps involved in method development and 
method validation are:               
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Method development plan definition 
↓ 
Background information gathering 
↓ 
Laboratory method development 
↓ 
Generation of Test Procedure 
↓ 
Method Validation Protocol definition 
↓ 
Laboratory Method Validation 
↓ 
Validated test method generation 
↓ 
Validation Report 
 
  A well developed method should be easy to validate. A method 
should be developed with the goal to rapidly test preclinical samples, 
formulation prototypes, and commercial samples. For validation, the 
developed method is subjected to the following studies.  
1.  Specificity 
            It is the ability of the method to accurately measure the analyte 
response in the presence of all potential sample components. The 
response of the analyte in test mixtures containing the analyte and all 
potential sample components (placebo formulation, synthesis 
Introduction 
 5
intermediates, excipients, degradation products, process impurities etc.) is 
compared with the response of a solution containing only the analyte.  
2.  Linearity 
 A linearity study verifies that the sample solutions are in a 
concentration range where the analyte response is linearly proportional to 
concentration. Acceptability of linearity data is often judged by examining 
the correlation coefficient and y-intercept of the linear regression line for 
the response versus concentration plot.  
3.  Range 
 The range of an analytical method is the concentration over which 
acceptable accuracy, linearity, and precision are obtained. In practice, the 
range is determined using data from the linearity and accuracy studies.  
4.  Accuracy       
 The accuracy of a method is the closeness of the measured value 
to the true value for the sample. Accuracy is usually determined in four 
ways:    
♦ It can be assessed by analyzing a sample of known concentration 
and comparing the measured value to the true value. 
♦ The second approach is to compare test results from the new 
method with the results from an existing alternate method that is 
known to be accurate.  
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♦ The third approach, which is the most widely used recovery study, 
is performed by spiking analyte in blank matrices. For assay 
methods, spiked samples are prepared in triplicate at three levels 
over a range of 50-150% of the target concentration.  
♦ The fourth approach is the technique of Standard additions, which 
can also be used to determine recovery of spiked analyte. 
5.  Precision 
 The precision of an analytical method is the amount of scatter in the 
results obtained from multiple analyses of a homogenous sample. It is 
determined at three levels.  
Repeatability 
 It is obtained when analysis is carried out in one laboratory by one 
operator using one piece of equipment over relatively short time span for 
at least 5 or 6 determinations of three different matrices at 2 or 3 different 
concentrations.    
 Reproducibility:  
 It represents the precision obtained between laboratories. The 
objective is to verify that the method will provide the same results in 
different laboratories. It is determined by analyzing aliquots from 
homogenous lots in different laboratories with different analysts with the 
specified parameters of the method. 
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6.  Limit of Detection (LOD) 
 The detection limit is the lowest analyte concentration that produces 
a response detectable above the noise level of the system, typically, three 
times the noise level.      S/N = 3/1 
7.  Limit of Quantitation (LOQ)  
 The quantitation limit is the lowest level of analyte that can be 
accurately and precisely measured. It is calculated as the analyte 
concentration that gives S/N = 10/1. 
8.  Robustness  
 The robustness of a method is its ability to remain unaffected by 
small changes in parameters such as % organic content and pH of mobile 
phase, buffer concentration, temperature and injection volume. 
 
Literature Review 
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LITERATURE REVIEW 4-7 
1. Shinde, D.B., et al have reported Spectrophotometric methods for 
the estimation of Tolterodine tartarate in Bulk and Tablet 
formulation. 
2. Kumar, Y.R., et al have reported a validated chiral HPLC method 
for the enantiomeric separation of Tolterodine tartarate. 
3. Vinay, S., et al have reported Stability-indicating HPLC  
determination of Tolterodine tartarate in pharmaceutical dosage 
form. 
4. Perfetto, E.M., et al has reported on Treatment of Overactive 
Bladder- A Model Comparing Extended – Release Formulations of 
Tolterodine and Oxybutynin.` 
Aim and plan of work 
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AIM AND PLAN OF WORK 
           Literature studies revealed that no method has been reported 
using Difference Spectroscopy, MBTH Reagent, HPTLC and RP-HPLC 
for the estimation of Tolterodine tartarate in the single dosage form. 
Hence, the aim and plan of study of this work is as given below: 
¾ Method Development and Validation for the Estimation of 
Tolterodine tartarate from the Tablet dosage form by Difference 
Spectroscopy.  
¾ Development of Validated Visible Spectrophotometric Method 
for the Estimation of Tolterodine tartarate from the Tablet 
dosage form. 
¾ Method Development and Validation for the Estimation of 
Tolterodine tartarate from the Tablet dosage form by HPTLC.  
¾ Method Development and Validation for the Estimation of 
Tolterodine tartarate from the Tablet dosage form by RP-HPLC. 
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DRUG PROFILE 8-10 
TOLTERODINE TARTARATE 
Structure : 
 
            
Molecular weight    :    475.57 
Molecular formula  :    C22H31NO. C4H6O6 
IUPAC Name          : 2-[(1R)-3-[Bis (1-methyl ethyl) amino]-1-  
                                     phenyl propyl]-4-methyl phenol 
Description             :   Tolterodine tartarate occurs as a white crystalline 
                                   powder. 
Solubility                :    Soluble in water, methanol. 
pKa                         :    9.9 
Indications              :   Used in the treatment of patients with Overactive 
bladder with symptoms of urge incontinence,  
urinary frequency. It is a competitive muscarinic 
receptor antagonist which mediates urinary 
bladder contraction. It increases residual urine 
volume and decreases detrussor muscle 
pressure.  
Storage                   :    At 25ºc 
Formulation            :   Roliten(Tolterodine tartarate 2mg), Ranbaxy  
                                  Laboratories Limited, India.  
OH 
H 
N
CH3 CH3 
CH3 
CH3 
H3C C4H6O6 • 
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MATERIALS AND INSTRUMENTS USED 
DRUG SAMPLE 
 Tolterodine tartarate was obtained as a gift sample from Ranbaxy 
Laboratories Limited, India. 
Chemicals and solvents 
¾ Methanol AR grade, HPLC grade (Qualigens Fine Chemicals, 
Mumbai.) 
¾ Water HPLC grade (Merck Private Limited.) 
¾ MBTH, A.R. (HiMedia Laboratories Pvt.Ltd.) 
¾ Cerric ammonium Sulphate (Loba Chemie) 
¾ Hydrochloric Acid LR grade (sd fine chem limited, Mumbai.) 
¾ Sulphuric Acid (Qualigens Fine Chemicals, Mumbai.) 
¾ Sodium Hydroxide LR grade (sd fine chem limited, Mumbai.) 
¾ Triethylamine AR grade (sd fine chem limited, Mumbai.) 
¾ Glacial acetic acid (sd fine chem, Mumbai.) 
¾ Chloroform (Qualigens Fine Chemicals, Mumbai.) 
INSTRUMENTS USED 
¾ Jasco V- 530 UV/VIS Spectrophotometer 
¾ Camag HPTLC System ( with Linomat 5 as application device, 
 TLCScanner 3 and winCATS Software ) 
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¾ Shimadzu HPLC Class LC-10 AT VP system(Photodiode array 
 detector) 
¾ Pall Gelman Sciences, Vacuum pump 
¾ Elico Pvt. Limited, India, pH meter – LI 127 
¾ Shimadzu Digital Electronics Balance – BL220H 
Introduction To Ultraviolet Absorption 
Spectrophotometry   
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INTRODUCTION TO ULTRAVIOLET 
ABSORPTION SPECTROPHOTOMETRY 11-12 
 
Ultraviolet Spectrophotometry is one of the most frequently 
employed techniques in pharmaceutical analysis. It involves the 
measurement of the amount of ultraviolet (190-380 nm) or 200-400 nm 
radiation or 2000-4000 Ǻ radiation absorbed by a substance in solution. 
The wavelengths in the ultraviolet region are usually expressed in 
angstrom (Ǻ) units or more commonly in millimicron or nanometer; 
occasionally absorption is reported in wave numbers.         
         Absorption of light in ultraviolet region of the electromagnetic 
spectrum occurs when the energy of light matches that required to induce 
in the molecule an electronic transition and its associated vibrational and 
rotational transitions. 
         A compound or drug possess conjugated double bond, absorbs UV 
radiation at a specific wavelength and this character of drug is specific for 
a fixed solvent system. The drugs are quantitatively analyzed by ultraviolet 
analytical method which is governed by Beer Lambert’s law, which is 
represented as 
A = abc 
where ,   a = absorptivity 
     A =absorbance   ,     b = path length      ,        c = concentration 
Introduction To Ultraviolet Absorption 
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QUANTITATIVE SPECTROPHOTOMETRIC ASSAY OF MEDICINAL 
SUBSTANCES 
1. Use of a calibration graph 
Statistical treatment of the calibration data, facilitated by micro 
computers or pre programmable calculators, provides a more elegant and 
accurate determination of the relationship between absorbance and 
concentration than manually constructed graphs.  If the absorbance values 
and concentrations bear a linear relationship, the regression line y = α + 
βx may be estimated by the method of least squares. 
                   α   =   ( )( ) ( )( )( )22
2
∑ ∑
∑∑∑∑
−
−
xxN
xyxxy
  
     β   =   ( )( )∑ ∑
∑ ∑∑
−
−
22 )( xxN
yxxyN
 
Where,  x   =   concentration   
   y   =   absorbance 
   N  =   number of pairs of values  
2.  Single - point standardization method 
The single -point procedure involves the measurement of the 
absorbance of a sample solution and of a standard solution of the 
reference substance. The standard and sample solutions are prepared in a 
similar manner. Ideally, the concentration of the standard solution should 
Introduction To Ultraviolet Absorption 
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be close to that of the sample solution. The concentration of the substance 
in the sample is calculated from the proportional relationship that exists 
between absorbance and concentration.   
ctest = Atest x cstd 
        Astd 
 
 Where c test and c std   are the concentrations in the sample and 
standard solutions respectively, and A test   A std are the absorbances of the 
sample and standard solutions respectively. Since sample and standard 
solutions are measured under identical conditions, this procedure is the 
preferred method of assay of substances that obey Beer's Law and for 
which a reference standard of adequate purity is available 
ASSAY OF SUBSTANCES IN MULTICOMPONENT SAMPLES 
 The various spectroscopic techniques used for multi-component 
analysis are as follows 
# Simultaneous equation method (Vierodt’s method)           
# Absorbance ratio method 
# Geometric correction method 
# Absorption factor method (absorption correction method) 
# Orthogonal polynomial method  
# Difference spectrophotometry 
# Derivative spectrophotometry 
 
Introduction To Ultraviolet Absorption 
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Simultaneous equation method 
 If a sample contains two absorbing drugs (X and Y) each of which 
absorbs at the λmax of the other, it may be possible to determine both 
drugs by the technique of simultaneous equation (Vierodt’s method). 
The information required is  
a) The absorptivities of X at λ1 and λ2 , ax1 and ax2, respectively. 
b) The absorptivities of Y at λ1 and λ2 , ay1 and ay2, respectively. 
c) The absorbances of the diluted sample at λ1 and λ2 , A1 and A2, 
 respectively. 
 Let Cx and Cy be the concentration of X and Y respectively in the 
diluted sample. 
 Two equations are constructed based upon the fact that at λ1 and 
λ2, the absorbance of the mixture is the sum of the individual absorbance 
of X and Y. 
At λ1  A1 = ax1bcx + ay1bcy 
At λ2  A2 = ax2bcx + ay2bcy 
Cx = 
2112
2112
yxyx
yy
aaaa
aAaA
−
−
 
Cy = 
2112
1211
yxyx
xx
aaaa
aAaA
−
−
   
 Using the above equations, concentration of individual component 
in a mixture can be determined by simple calculation. 
Introduction To Ultraviolet Absorption 
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Absorbance ratio method 
           The absorbance ratio method is a modification of the simultaneous 
equation procedure. It depends on the property that, for a substance which 
obeys Beer law at all wavelengths, the ratio of absorbances at any two 
wavelengths is a constant value independent of concentration or path 
length. Two different dilutions of the same substance which gives the 
same absorbance ratio is referred to as Q value. 
          In the quantitative assay of two components in admixture by the 
absorbance ratio method, absorbance are measured at two wavelengths, 
one being the λmax of one of the components and the other being a 
wavelength of equal absorptivity of the two components, i.e. an iso-
absorptive point. 
Geometric correction method: 
          This method reduces or eliminates the background irrelevant 
absorption that may be present in samples of biological origin. This is 
applied if the irrelevant absorption is linear at the three wavelengths 
selected.  
          Consider an absorption spectrum comprising the spectrum of an 
analyte and that of the background absorption. If the wavelengths λ1, λ2 
and λ3 are selected so that the background absorbances B1, B2 and B3 are 
linear, then the corrected absorbance, D of the drug may be calculated 
from the three absorbances A1, A2 and A3 of the sample solution at λ1, λ2 
Introduction To Ultraviolet Absorption 
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and λ3. Vitamin A is assayed by this method. 
                               D = y (A2-A3)+z(A2-A1) 
                                         (y+z) (1-r) 
Orthogonal polynomial method: 
          This technique is another mathematical correction procedure which 
involves more complex calculations than the three-point correction 
procedure. The basis of the method is that an absorption spectrum may be 
represented in terms of orthogonal functions as follows: 
                  A (λ) = p0P0 (λ) + p1P1 (λ) + p2P2 (λ)…. PnPn (λ) 
where A denotes the absorbance at wavelength λ belonging to a set of 
n+1 equally spaced wavelengths at which the orthogonal 
polynomials,P0(λ), P1(λ), P2(λ)….Pn(λ) are each defined. These 
polynomials represent a series of fundamental shapes.  
          The coefficients are proportional to the concentration of the 
absorbing analyte, and a modified Beer-Lambert’s equation may be 
constructed.  
                   pj = αjbc 
pj  = the coefficient of the polynomial 
αj  = proportionality constant analogous to absorptivity. 
          The accuracy of the orthogonal functions procedure depends on the 
correct choice of the polynomial order and set of the wavelengths. The set 
of wavelengths is defined by the number of wavelengths, the interval and 
Introduction To Ultraviolet Absorption 
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the mean wavelength of the set (λm). The wavelength interval and λm are 
best obtained from a convoluted absorption curve. This is a plot of the 
coefficient (pj) for a specified order of polynomial, a specified number of 
wavelengths and a specified wavelength interval against the λm of the set 
of wavelengths. 
Derivative spectrophotometry 
 Derivative spectrophotometry involves the conversion of a normal 
spectrum to its first, second or higher derivative spectrum. The 
transformations that occur in the derivative spectra are understood by 
reference to a Gaussian band, which represents an ideal absorption band. 
 The first derivative (D1) spectrum is a plot of the rate of change of 
absorbance with wavelength against wavelength or a plot of dA/dλ. The 
second derivative (D2) spectrum is a plot of the curvature of the D° 
spectrum against wavelength or a plot of d2/dλ2 vs λ. 
 These spectral transformations confer two principal advantages on 
derivative spectrophotometry. 
a) Derivative spectrum shows better resolution of overlapping bands 
than the fundamental spectrum and may permit the accurate 
determination of the λmax of the individual bands. 
b)        Derivative spectrophotometry discriminates in favour of substances 
of          narrow spectral bandwidth against broad bandwidth substances. 
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INTRODUCTION TO DIFFERENCE 
SPECTROSCOPY11-15 
 Difference Spectroscopy, provides a sensitive method for 
detecting small changes in the environment of a chromophore, or it can 
be used to demonstrate ionization of a chromophore leading to the 
identification and quantification of various components in a mixture. In 
difference spectroscopy, absorption spectra of two samples of slightly 
different composition or physical state are compared. 
 In difference spectroscopy, a double-beam instrument is used to 
measure the difference in absorbance between the two samples. 
Instead of a blank solution, one of the two solutions is placed in the 
path of the reference beam of the spectrophotometer. The other 
solution is placed in the usual position in the path of the sample beam. 
The instrument measures the difference in absorbance between the 
two samples. Difference spectrophotometry is particularly useful for 
measuring small differences between two, nearly identical solutions. 
Difference spectra are particularly useful for determining qualitative 
differences between two solutions.  
The selectivity and accuracy of spectrophotometric analysis of 
samples containing absorbing interferents may be markedly improved 
by the technique of difference spectrophotometry. The essential feature 
of a difference spectrophotometric assay is that the measured value is 
Introduction To Difference Spectroscopy 
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the difference absorbance (∆A) between two equimolar solutions of the 
analyte in different chemical forms which exhibit different spectral 
characteristics.  
  The criteria for applying difference spectrophotometry to the 
assay of a substance in the presence of other absorbing substances 
are that: 
¾   Reproducible changes may be induced in the spectrum of the 
analyte by the addition of one or more reagents. 
¾  The absorbance of the interfering substances is not altered by 
the reagents. 
 The simplest and most commonly employed technique for 
altering the spectral properties of the analyte is the adjustment of the 
pH by means of aqueous solutions of acid, alkali or buffers. The 
ultraviolet-visible absorption spectra of many substances containing 
ionisable functional groups, e.g., phenols, aromatic carboxylic acids 
and amines are dependent on the pH of the solution. The difference 
absorption spectrum is generated automatically using a double beam 
recording spectrophotometer. 
 The measured value in a quantitative difference 
spectrophotometric assay is the ∆A at any suitable wavelength 
measured to the baseline. 
∆A = Aalk - Aacid 
Introduction To Difference Spectroscopy 
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 where, Aalk and Aacid are the individual absorbances at 
wavelength in different medium. 
           If Aalk and Aacid are proportional to the concentration of the 
analyte and pathlength, the ∆A obeys Beer-Lambert law and a modified 
equation may be derived. 
∆A = ∆abc 
where, ∆a = difference absorptivity of the substance at the wavelength 
of measurement. 
 If one or more other absorbing substances are present in the 
sample which at the analytical wavelength has identical absorbance 
(Ax) in the alkaline and acidic solutions, its interference in the 
spectrophotometric measurement is eliminated. 
∆A    =  (Aalk + Ax) - (Aacid - Ax) 
                                                       =  Aalk - Aacid 
  The selectivity of the ∆A procedure depends on the correct 
choice of the pH values to induce the spectral change of the analyte 
without altering the absorbance of the interfering components of the 
sample. The use of alkali and analyte to induce the ∆A of the analyte is 
convenient and satisfactory when the irrelevant absorption arises from 
pH-insensitive substances. 
           The selection of two buffers, one at a pH two units greater than, 
and the other at a pH two unit less than, the pKa of the analyte, ensure 
Introduction To Difference Spectroscopy 
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that the analyte is 99% in the ionized state and that the ∆A is most 
maximal. 
         A substance whose spectrum is unaffected by changes of pH 
may be determined by a difference spectrophotometric procedure if it 
can be quantitatively converted by means of a suitable reagent to a 
chemical species that has different spectral properties to its unreacted 
parent substance. 
         The ∆A between equimolar solutions of the unreacted substance 
and its derivative is free of interference if the irrelevant absorption is 
unaffected by the reagent 
Applications 
1. Difference spectroscopy is utilized in toxicology laboratories for 
analysis of dangerous drugs. 
2. It is used to study the conformation of globular proteins in 
solution. 
3. The difference spectrum gives the information which has been 
obtained using solvent perturbation, pH difference, temperature 
difference and concentration difference etc. 
Experimental section 
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METHOD  DEVELOPMENT  AND  VALIDATION  FOR  THE 
ESTIMATION  OF  TOLTERODINE  TARTARATE FROM TABLET 
DOSAGE FORM BY  DIFFERENCE  SPECTROSCOPY 
 
METHOD DEVELOPMENT 
1.  Selection of Solvent and Wavelength 
 From the literature studies, solubility studies, it was found that 
Tolterodine tartarate was soluble in water and the drug showed good 
stability in this solvent. The drug was dissolved in water and the 
absorbance and spectral pattern was noted. Tolterodine tartarate showed 
a λmax of 282 nm in water. The absorption spectrum is shown in Fig. 1. 
Fig.1  :  Absorption spectrum of Tolterodine tartarate in water 
 
2. Preparation of stock solution 
 10 mg of Tolterodine tartarate was weighed and transferred        
into a 100 ml standard flask, dissolved in water and made upto        
volume with the same to get a concentration of 100 µg/ml.
Experimental section 
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3.  Difference Spectroscopy 
i)  Optimizing the molarity of hydrochloric acid 
 Stock solution of 5.0 ml was pipetted into a series of 10 ml standard 
flasks .To this, different molarities of hydrochloric acid such as 1M, 0.5M, 
0.1M, 0.05M, 0.01M, 0.005M, 0.001M were added and made upto volume 
with the same to produce solutions of concentration 50 µg/ml. The 
absorbance and spectral pattern were noted and the absorbance was 
found to be the highest for 0.5M HCl. (Table :1 and  Fig. 2) 
Table 1: Fixing the Molarity of Hydrochloric acid 
Concentration 
(µg/ml) 
Molarity Absorbance 
0.001M 0.2870 
0.005M 0.3029 
0.01M 0.2971 
0.05M 0.2954 
0.1M 0.3410 
0.5M* 0.3877 
50 
1M 0.3213 
* Selected parameter 
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Fig. 2  : Optimizing the molarity of  hydrochloric acid 
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ii)  Optimizing the molarity of sodium hydroxide 
 Stock solution of 5.0 ml was pipetted into a series of 10 ml standard 
flasks. To this, different molarities of Sodium hydroxide such as 1M, 0.5M, 
0.1M, 0.05M, 0.01M, 0.005M, 0.001M were added and made upto volume 
with the same to produce solutions of concentration 50 µg/ml. The 
absorbance and spectral pattern were noted and the absorbance was 
found to be the highest for 0.5M NaOH. (Table:2 and Fig. 3) 
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Table 2 : Fixing the Molarity of Sodium hydroxide 
Concentration 
(µg/ml) 
Molarity Absorbance 
0.001M 0.0848 
0.005M 0.3400 
0.01M 0.4038 
0.05M 0.4532 
0.1M 0.4704 
0.5M* 0.4795 
50 
1M 0.4780 
* Selected parameter 
Fig. 3 :  Optimizing the molarity of  sodium  hydroxide 
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iii)  Obtaining the Difference Spectra 
 The difference spectra of equimolar solutions (0.5 M) of Tolterodine 
tartarate, an urogenital antispasmodic agent, in both HCl and NaOH were 
taken and are shown in Fig. 4. 
Fig. 4  : Difference spectra 
 
 The use of this concentration to induce the ∆A of the analyte was 
convenient and satisfactory. Hence, this molarity was chosen for the 
proposed study. 
iv) Preparation of Calibration Graph 
 Aliquots of stock solution (100 µg/ml) of the drug ranging from 1 to 9 
ml were transferred to two sets of a series of 10 ml volumetric flasks. One 
set of the stock solution was diluted with 0.5M HCl to volume and the 
second set was diluted with 0.5M NaOH to volume. Difference spectrum 
was recorded by placing same concentration of the acidic and alkaline 
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solution in the reference and sample cell respectively. The overlay spectra 
of standards are shown in Fig. 5. Difference of absorbance at two different 
wavelengths - 280 nm and 305 nm was calculated. (Table : 3). The 
difference in absorbance (∆A) was plotted versus concentration (10-90 
µg/ml), calibration curve was constructed, and the slope, intercept and 
regression equation was calculated. (Fig. 6) 
Table 3 : Difference in absorbance values of Tolterodine tartarate 
Absorbance Concentration 
( µg/ml) 305 nm 280 nm 
∆A 
10 0.1322 -0.0046 0.1368 
20 0.2422 -0.0408 0.2830 
30 0.3414 -0.0768 0.4182 
40 0.4449 -0.1182 0.5632 
50 0.5514 -0.1497 0.7012 
60 0.64684 -0.1917 0.8386 
70 0.7568 -0.2259 0.9827 
80 0.8519 -0.2627 1.1146 
90 0.9836 -0.2807 1.2643 
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Fig. 5 :  Overlay spectra of  standards 
 
Fig. 6 : Calibration graph of Tolterodine tartarate 
 
iv)  Estimation of Formulation 
 Twenty tablets (Roliten 2mg, Ranbaxy Laboratories Limited., India) 
were weighed and the average weight was determined. The powder 
equivalent to 10 mg was transferred to a 100 ml standard flask and 
extracted with distilled water by shaking for one hour. The solution was 
filtered through a Whatman filter paper. From this, aliquots of acidic and 
µg/ml 
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alkaline solutions of concentrations 30, 40, 50 µg/ml were prepared. The 
difference spectras of the appropriately diluted acidic and alkaline 
solutions were recorded. The amount of Tolterodine tartarate present in 
the sample solution was computed from the calibration graph. (Table : 4). 
Table 4  : Analysis of Formulation 
Amount (mg/tablet) 
Formulation 
Labeled Found 
% Label claim* 
± S.D. 
Roliten 2 1.97 98.3 ± 0.69 
* Mean of six determinations 
METHOD VALIDATION 
i)  Specificity 
 The developed method was found to be highly specific as there 
were no interferences with the excipients in the formulation. 
ii) Linearity and range 
 The developed method showed good linear relationship in the 
concentration range 10-90 µg/ml and the slope, intercept and correlation 
coefficient was found to be 0.0140, -0.0004 and 0.9999 respectively. Molar 
absorptivity and Sandell’s sensitivity was found to be 5392.01 l/mole/cm 
and 0.0885 µg/cm/0.001AU respectively. 
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iii)  Accuracy 
 The accuracy of the method was determined through recovery 
studies. To 10 mg equivalent of Tolterodine tartarate, the standard drug of 
Tolterodine tartarate was added at 100% level. The recovery procedure 
was repeated 6 times and the %recovery and %RSD was calculated 
(Table : 5) using the formula: 
% recovery = b-a/ c × 100 
Where,  a = amount of drug found before addition of standard drug. 
 b  = amount of drug found after addition of standard drug. 
 c  = amount of standard drug added. 
 
Table   : 5 Recovery Studies 
Drug % Recovery* %RSD 
Tolterodine 
tartarate 102.13 0.94 
* Mean of six determinations 
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Results and Discussion 
 A simple, precise and rapid difference spectroscopic method was 
developed for the estimation of Tolterodine tartarate from its tablet dosage 
form. This method was based on the technique of altering the spectral 
properties of the analyte by adjusting the pH by means of 0.5M HCl and 
0.5M NaOH. There were no interferences found with the excipients in the 
formulation. The content of Tolterodine tartarate was found to be 1.97 
mg/tab. The %recovery was found to be 102.13% ± 0.94 at 100% level 
which indicated the accuracy and reliability of the method. Hence, the 
developed method can be used for the routine analysis of Tolterodine 
tartarate in its tablet dosage form. 
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INTRODUCTION TO VISIBLE 
SPECTROSCOPY 3,11-17 
 
Visible Spectrophotometry is one of the most frequently used 
techniques in pharmaceutical analysis. It involves the measurement of 
visible (380-800 nm) radiation by a substance in solution. The variation of 
colour of a system with change in the concentration of the same 
components forms the basis of colorimetric analysis. The colour is usually 
due to the formation of a coloured complex by addition of the appropriate 
reagent. The intensity of the colour may then be compared with that 
obtained by treating a known amount of the substances in the same 
manner. Colorimetry is concerned with the determination of the 
concentration of a substance by the measurement of relative absorbance 
of light with respect to a known concentration of the substances.   
Chromophore 
 A chromophore is a group responsible for light absorption by a 
molecule. Originally, the term chromophore was applied to the system 
responsible for imparting colour to the compound. Most chromophore 
therefore contains only one or more multiple bonds. For example, in azo 
dyes, the aryl conjugated azo group (Ar-N=N-Ar) is clearly the principle 
chromophore and in nitro compounds, the yellow colour is carried out by 
NO2 group. 
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The term has been retained within an extended interpretation to 
simply any functional group that absorbs electromagnetic radiation, 
whether or not a ‘colour’ is thereby produced. Thus, the carbonyl group is 
a chromophore. 
Auxochrome 
An auxochrome was an earlier defined term for a group that could 
enhance the colour imparting properties of a chromophore without being 
itself a chromophore. Example: OR, -NH2, - NR2 etc. 
When a substance does not possess suitable chromogenic 
properties, it may be made to react with an absorbing species reagent and 
converted to an absorbing species. Reagents like Gibbs reagent, Ehrlich’s 
reagent, Folin-ciocalteu’s reagent, etc., can be used to convert the 
substance to a chromogen. 
Absorption spectrophotometry in the ultra violet and visible region is 
considered to be one of the physical methods used for the quantitative 
analysis and structural elucidation. In developing these new colorimetric 
methods, the systematic investigations were performed in the following 
manner. 
I. Spectral characteristics of the coloured species 
Absorption spectra against a solvent blank in the visible and near 
ultraviolet range (300-700nm) are recorded for the reagent alone and for 
the reagent in the presence of various proportions of the drug to be 
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determined. The proportions are chosen in such a way so that the 
absorbing species between the limits of the drug in large excess and the 
reagent are identified, for maximum sensitivity and greatest precision. The 
wavelength region at which the two solutions shows the largest difference 
in the absorbance is chosen for use in the determination, and the 
subtractive absorption spectrum of the coloured species against a reagent 
blank is obtained experimentally. 
II. Effect of pH 
The pH is more closely controlled and varied using fixed 
concentration of the reagent and the drug to be determined (in the 
presence of known excess of reagent). The absorbance of each solution is 
measured against the reagent blank at the same pH; after following 
definite time interval for complete colour development, over a relatively 
narrow band of wavelength (5-10 nm) near to the wavelength of maximum 
absorbance of coloured species as determined from the original 
absorption spectra.  
III.  Effect of Reagent Concentration 
The basis of most spectrophotometric methods is usually  
1. A complex formation reaction 
2. An oxidation-reduction process or  
3. A catalytic effect  
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In each of the reaction, the absorbance of the coloured species is 
measured and thus the sensitivity of the method is effected by the reagent 
(or catalyst) concentration, and therefore it is important to establish the 
concentration of the reagent, revised at several concentrations of the 
species to be determined. 
IV.  Order of Addition, Rate of Colour Formation and Stability 
The order in which the reagents are mixed often has a marked 
effect on the colour reaction and the rate of colour development. The 
absorbance produced at the optimum wavelength, pH and reagent 
concentration of the species to be determined are compared for different 
orders of mixing and colour development times. The plot of absorbance 
versus development times with the optimum order of addition reveals that 
the absorbance reaches a constant reproducible maximum value after a 
relatively short development time, and then remains constant for a 
considerably longer period. The stability of the colour produced is studied 
further over periods of time greater than those investigated during the 
colour development experiments. 
V.  Effect of Temperature 
Many of the reactions employed, on the basis of spectrophotometric 
determination are temperature dependent. The manner in which the 
absorbance varies with the temperature at which the colour is developed is 
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investigated over the range of temperature likely to be encountered in the 
laboratory. 
VI.  Nature of Coloured Species 
This method most frequently employed to investigate the reagent 
and drug ratio in a coloured species which forms the basis of a new 
method is determined through absorbance measurements in solution via 
the mole ratio, slope ratio and continuous variation procedures. If these 
methods are not suitable the nature of coloured species is predicted 
through the information as given in literature.  
Efforts are made to extract the coloured species from the aqueous 
to organic solvents media using common polar and non-polar water-
immiscible solvents with a view to get coloured species of better 
absorbance and stability reducing the interference of other associating 
constituents. Solvents extraction is proposed only when there are any 
positive additives. 
VII.  Calibration curve and optimum concentration range 
 A calibration curve for the determination of the drug is constructed 
by measurement of the absorbance developed by known concentrations of 
the constituents under optimum conditions against reagent blank. A 
straight line is obtained if Beer’s law is followed. 
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 DEVELOPMENT OF VALIDATED VISIBLE SPECTROPHOTOMETRIC 
METHOD FOR THE ESTIMATION OF TOLTERODINE TARTARATE 
FROM TABLET DOSAGE FORM 
 
1. Principle  
 Tolterodine tartarate contains a phenolic hydroxyl group which 
contributed in giving a purple colored chromogen in the presence of MBTH 
and cerric ammonium sulphate. This reaction is based on the oxidative 
coupling of Tolterodine tartarate in the presence of Ce(IV). On oxidation 
with Ce(IV), 3–methyl–2–benzothiazolinone hydrazone hydrochloride 
(MBTH) loses two electrons and one proton to give an electrophilic 
intermediate, which has been considered to be the active coupling 
species. When this intermediate reacts with one of the nucleophilic sites of 
Tolterodine tartarate by an electrophilic attack, it yields a purple colored 
complex. The chromogen formed has an absorption maximum of 552 nm. 
Beer’s law is obeyed in the range of 20-120 µg/ml. (Fig. 7, 8) 
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Fig. 7  : UV Spectrum of Tolterodine tartarate 
 
Fig. 8  : Developed chromogen 
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2. Development of the Colorimetric method  
a) Optimization of colorimetric parameters  
¾ Fixing the molarity of hydrochloric acid for the stock solution  
 10 mg of Tolterodine tartarate was added into a series of 10 ml 
standard flasks and was made upto volume with different molarities of 
hydrochloric acid such as 0.01M, 0.1M, 0.5M, 1M HCl to get 
concentrations of 1000µg/ml. The drug did not dissolve in 0.5M and 1M 
HCl. The drug showed highest absorbance and good spectral pattern in 
0.1M HCl. So, 0.1M HCl was selected for the preparation of the standard 
stock solution (Fig. 9). 
Fig.9  : Fixing the molarity of hydrochloric acid 
 
¾  Fixing the molarity of sulphuric acid for the preparation of 
cerric ammonium sulphate  
 0.003M Cerric ammonium sulphate was prepared by weighing 
0.0474 gm of cerric ammonium sulphate into a series of 25 ml standard 
flasks, dissolved and made upto volume with different molarities of 
Experimental Section 
 42
Sulphuric acid such as 0.001M, 0.01M, 0.1M, 0.5M, 1M, 1.5M. Standard 
Stock Solution of 0.6 ml was added into a series of 10 ml standard flasks. 
To these, 2 ml of 0.2% MBTH solution and 4 ml of cerric ammonium 
sulphate dissolved in different molarities of Sulphuric acid were added. 
The solutions were kept aside for 30 minutes to favor complex formation 
and made upto volume with distilled water. The absorbances of these 
solutions were read against reagent blank (Table : 6). The solution showed 
highest absorbance and good spectral pattern with 0.003M cerric 
ammonium sulphate dissolved in 0.01M Sulphuric acid (Fig. 10). 
Table  6   : Fixing the molarity of Sulphuric acid 
 
Molarity of Sulphuric acid 
 
Absorbance 
0.001M 0.4560 
0.01M* 0.6382 
0.1M 0.4505 
0.5M 0.4027 
1M 0.4051 
1.5M 0.3279 
* Selected parameter 
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Fig.10 :  Fixing the Molarity of Sulphuric acid 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0.001 0.01 0.1 0.5 1 1.5
Molarity
A
bs
or
ba
nc
e
 
¾          Fixing the strength of cerric ammonium sulphate  
             Standard Stock Solution of 0.6 ml was added into a series of 10 ml 
standard flasks. To these, 2 ml of 0.2% MBTH solution and 4 ml of 
different molarities of cerric ammonium sulphate such as 0.001M, 0.002M, 
0.003M, 0.004M, 0.005M and 0.01M were added. The solutions were kept 
aside for 30 minutes to favor complex formation and made upto volume 
with distilled water. The absorbance's of these solutions were read against 
reagent blank (Table : 7). The solution showed highest absorbance and 
good spectral pattern with 0.004M Cerric Ammonium Sulphate (Fig.11). 
Experimental Section 
 44
Table : 7  Fixing the strength of cerric ammonium sulphate 
Strength of cerric ammonium 
sulphate Absorbance 
0.001M 0.4561 
0.002M 0.5109 
0.003M 0.6635 
0.004M* 0.7935 
0.005M 0.7832 
0.01M 0.6382 
* Selected parameter 
Fig.11  : Fixing the strength of cerric ammonium sulphate 
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¾ Fixing the volume of cerric ammonium sulphate  
            Standard Stock Solution of 0.6 ml was added into a series of 10 ml 
standard flasks. To these, 2 ml of 0.2% MBTH solution and different 
volumes of 0.004M cerric ammonium sulphate such as 1, 2, 3, 4, 5 ml 
were added. The solutions were kept aside for 30 minutes to favor 
complex formation and made upto volume with distilled water. The 
absorbances of these solutions were read against reagent blank       
(Table : 8). The solution showed highest absorbance and good spectral 
pattern with 2 ml of 0.004M cerric ammonium sulphate (Fig. 12). 
 
Table  8   : Fixing the volume of cerric ammonium sulphate 
Volume of cerric ammonium 
sulphate (ml) Absorbance 
1 0.3881 
2* 0.7862 
3 0.7454 
4 0.7275 
5 0.6864 
               * Selected  parameter 
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Fig. 12 Fixing the volume of cerric ammonium sulphate 
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¾ Fixing the strength of MBTH solution  
 Standard Stock Solution of 0.6 ml was added into a series of  
10 ml standard flasks. To these, 2 ml of different concentrations of MBTH 
solutions such as 0.1%, 0.2%, 0.3%, 0.4%, 0.5% and 2 ml of 0.004M 
cerric ammonium sulphate were added. The solutions were kept aside for 
30 minutes to favor complex formation and made upto volume with distilled 
water. The absorbances of these solutions were read against reagent 
blank. The solution showed highest absorbance and good spectral pattern 
with 0.1% MBTH solution (Table 9 & Fig.13). 
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Table  9  :  Fixing the strength of MBTH 
Strength of MBTH (%w/v) Absorbance 
0.1* 0.6288 
0.2 0.4594 
0.3 0.2933 
0.4 0.2448 
0.5 0.2096 
 * Selected parameter 
Fig. 13 : Fixing the strength of MBTH 
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¾ Fixing the volume of MBTH solution  
           Standard Stock Solution of 0.6 ml was added into a series of 10 ml 
standard flasks. To these, different volumes of 0.1% MBTH solution such 
as 0.05, 1, 2, 3, 4, 5 ml and 2 ml of 0.004M cerric ammonium sulphate 
were added. The solutions were kept aside for 30 minutes to favor 
complex formation and made upto volume with distilled water. The 
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absorbances of these solutions were read against reagent blank        
(Table 10). The solution showed highest absorbance and good spectral 
pattern with 3 ml of 0.1% MBTH solution (Fig. 14). 
Table  10  : Fixing the volume of MBTH 
Volume of MBTH (ml) Absorbance 
0.05 0.6449 
1 0.7441 
2 0.7662 
3* 0.7771 
4 0.6516 
5 0.4718 
* Selected parameter 
Fig. 14 : Fixing the volume of MBTH 
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b) Preparation of standard graph  
 Aliquots of standard stock solution of volume 0.2, 0.4, 0.6, 0.8, 1.0, 
1.2 ml were added into a series of 10 ml standard flasks. To these, 3 ml of 
0.1% MBTH solution and 2 ml of 0.004M cerric ammonium sulphate was 
added. The solutions were kept aside for 30 minutes to favor complex 
formation and made upto volume with distilled water. The absorbances of 
these solutions were noted at 552 nm against reagent blank. A standard 
graph was obtained by plotting concentration of standard solutions Vs 
absorbance (Fig. 15). The slope, intercept and correlation coefficient were 
found to be 0.0087, 0.0279 and 0.9970 respectively. Tolterodine tartarate 
showed good linear relationship in the concentration range 20-120 µg/ml 
with the molar absorptivity of 4314.37 l/mole/cm and the Sandell’s 
sensitivity was found to be  0.1106 µg /cm/0.001AU (Table : 11). 
Table 11  : Absorbance values of Tolterodine tartarate 
 
Concentration 
(µg/ml) 
Absorbance at 552 nm 
20 0.1654 
40 0.3893 
60 0.5813 
80 0.7325 
100 0.8831 
120 1.0505 
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Fig.  15  : Calibration graph of Tolterodine tartarate 
 
 
 
 
 
 
 
 
 
 
Analysis of Formulation 
           20 tablets (Roliten, Ranbaxy Laboratories Limited, India) were 
weighed and the average weight was calculated. A quantity equivalent to 
10 mg of Tolterodine tartarate was weighed and transferred to a 10 ml 
standard flask, dissolved in 0.1M HCl and made upto volume with the 
same. It was then filtered through Whatman filter paper. From this stock 
solution, 0.6 and 0.8 ml were pipetted into 10 ml standard flasks. To these, 
3 ml of 0.1% MBTH solution and 2 ml of 0.004M cerric ammonium 
sulphate was added. The solutions were kept aside for 30 minutes to favor 
complex formation and made upto volume with distilled water. The 
absorbances of these solutions were noted at 552 nm against reagent 
µg/ml  Conc. µg/ml 
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blank and the amount of drug present in the formulation was calculated 
(Table :12) by single-point standardization method and the equation is as  
follows:    ctest = Atest x cstd   
     Astd 
 
Table  12  : Analysis of Formulation 
Amount(mg/tablet)  
Formulation Labeled Found 
%Label 
Claim*± S.D 
Roliten 
 
2 
 
 
1.97 
 
 
98.5±0.32 
 
*Mean of six determinations 
a) Stability studies  
 Stability studies were carried out at room temperature and the 
absorbance of the chromogen was measured with respect to time (Table 
13) The color was found to be stable for 1 hour (Fig. 16).  
 
Table  13   :  Stability Studies 
Time(min) Absorbance 
0 0.4376 
30 0.4268 
60 0.4232 
90 0.2997 
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Fig. 16 : Stability Studies 
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METHOD VALIDATION 
 The developed method was validated as per ICH Guidelines in 
terms of specificity, linearity, range, precision and accuracy. 
i) Accuracy  
 Accuracy of the developed method was determined by conducting 
the recovery studies. To the powder formulation equivalent to 10 mg of 
Tolterodine tartarate, standard drug of Tolterodine tartarate was added at 
100% level. The concentration of the drug present in the resulting 
solutions was determined by the proposed method. The recovery 
procedure was repeated six times and the %recovery was calculated 
(Table : 14).                 
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Table 14 : Recovery Studies 
Formulation %Recovery* % RSD 
Roliten 98.3 0.76 
*Mean of six determinations   
 
ii)  Specificity 
 The developed method was found to be highly specific as there 
were no interferences found with the excipients used in the formulation. 
 
iii)  Precision 
 Precision of the method was determined by the repeatability 
studies. Intra-day and inter-day assays were carried out with the method 
by repeating the procedure six times and the %RSD was calculated. The 
datas are shown in (Table : 15 and 16). 
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Table 15   : Intra-day Precision 
Drug Concentration (µg/ml) Absorbance %RSD* 
0.3893 
0.3890 
0.3892 
0.3896 
0.3899 
Tolterodine 
tartarate 40 
0.3892 
0.12 
*Mean of six determinations 
Table 16  : Inter-day Precision 
Drug Concentration (µg/ml) Days Absorbance %RSD* 
0.3893 
0.3890 
0.3892 
0.3896 
0.3899 
1st 
0.3892 
 
0.12 
0.3895 
0.3893 
0.3891 
0.3897 
0.3892 
Tolterodine 
tartarate 40 
2nd 
0.3893 
0.24 
*Mean of six determinations 
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iv)  Linearity and Range 
           Tolterodine tartarate showed good linearity in the concentration 
range of 20 – 120 µg/ml and the slope, intercept and correlation coefficient 
was found to be 0.0087, 0.0279 and 0.9970 respectively. Molar 
absorptivity was found to be 4314.37 l/mole/cm and Sandell’s sensitivity 
was found to be 0.1106 µg/cm/0.001AU. 
Results and Discussion 
 
             The results obtained by the proposed colorimetric method for the 
estimation of Tolterodine tartarate in the tablet dosage form showed that 
the amount recovered was in good agreement with the label claim of the 
formulation. The method was simple, precise and accurate and can be 
employed for the routine analysis of Tolterodine tartarate in the tablet 
dosage form. The recovery of the sample was close to 100% indicating the 
accuracy, reliability and reproducibility of the method. 
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 INTRODUCTION TO HPTLC18-22 
HPTLC is the most simple separation technique today available 
to the analyst. HPTLC is a qualitative tool for separation of simple 
mixtures where speed, low cost and simplicity are required and it is 
also a tool for quantitative analysis with high sample throughput. 
Selection of chromatographic layer 
Pre-coated plates with different support material, sorbent layer 
and with different sorbent thickness of 100-250µm are used for 
quantitative and qualitative analysis. 
Pre-washing and activation of pre-coated plates 
Sorbents on the plate absorb water vapour, impurities and other 
volatile substances from atmosphere which gives dirty zones on 
development and fail to give reproducible results. The plates are 
cleaned by a method referred to as pre- washing. 
The plates are activated by drying in drying cupboards for 
sufficient time to ensure removal of the washing liquids (Usually, for 
methanol 30-60 min at 105°). Plates are then stored in dust free 
atmosphere under ambient condition. 
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Sample preparation 
This procedure involves, dissolving the dosage form in a solvent 
with complete recovery of intact compounds of interest and minimum of 
matrix with suitable concentration of analyte during extraction and 
analysis must be considered and ensured. 
Sample application 
Sample application is one of the most critical step for obtaining 
good resolution for quantification by HPTLC. The sample should be 
applied through clean upper end of the capillary to marked point. 
Usually application of 1-10 µl for HPTLC is recommended. Samples 
are applied as bands as it offers better separation, higher response of 
densitometer, smaller spot broadening etc. 
Mobile phase 
Mobile phase (Solvent system) is selected by trial and error 
method. Mobile phase should be chosen by taking into consideration 
chemical properties of analytes and the sorbent layer. Mobile phase 
containing more than 3 or 4 components should be avoided as it is 
often difficult to get reproducible ratios. 
Preconditioning (Chamber saturation) 
In a saturated chamber, the solvent vapors get uniformly 
distributed throughout the chamber. As soon as the plate is placed in a 
Introduction to HPTLC  
 
58
saturated chamber it soon gets pre loaded with solvent vapour, hence 
less solvent is only required, resulting in lower Rf values. 
Development and drying 
Ascending, descending, 2-dimensional, horizontal, gradient, 
radial, multidimensional etc. are the most common mode of 
chromatographic development. Rectangular glass chambers, twin-
trough chambers, V-shaped chambers etc. are commonly used for 
carrying out different types of TLC development. 
Detection and visualization 
The characteristic features of TLC/ HPTLC is the possibility to 
utilize post chromatographic off line derivatisation. Detection under UV 
light is the most preferred method as it is non-destructive and 
commonly employed for densitometric scanning. 
Criteria for selection of most suitable wave length 
The light intensity remitted by chromatographic zones is usually 
lower than the sorbent layer around it. Therefore, absorption spectra of 
a compound can directly be determined on HPTLC plate itself in 
comparison to substance free portion of sorbent layer. 
Scanning is mostly carried out at a wave length of maximum 
absorption because the difference between, absorption by the 
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chromatographic zone and the blank area of sorbent layer around it is 
the largest, background being least. 
In case of complex formulations, the analyst should explore the 
possibility of selecting a single wavelength at which the entire 
chromatogram could be scanned referred to as “most suitable 
wavelength”. 
While selecting single wavelength, the interest of minor 
components in the formulation needs special consideration. 
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METHOD  DEVELOPMENT  AND  VALIDATION  OF  TOLTERODINE  
TARTARATE  IN  TABLET  DOSAGE  FORM    BY  HPTLC 
 
1. Selection of Solvent                                                                                               
         The drug is dissolved in a solvent in which it is soluble and in 
which the drug showed good stability. Another criteria for the selection 
of solvent is that it has to be volatile, cheap and easily available. As 
Tolterodine tartarate is readily soluble in methanol and showed good 
stability, it was selected as the solvent. 
2 Selection of Detection Wavelength   
  An ideal wavelength is the one that gives maximum absorption 
and good response for the drug to be detected. UV spectrum of the 
drug showed maximum absorption at 282 nm which was selected as 
the detection wavelength. (Fig .17). 
3. Optimization of the Mobile phase  
     Based on the property of polarity, solubility, various mobile 
phases were tried.  
¾ The spot did not migrate with toluene: chloroform: glacial 
acetic acid (8:2:0.5 %v/v/v). 
¾   The spot did not migrate with toluene: ethyl acetate: glacial 
acetic acid (8:2:0.5 %v/v/v). 
¾ With methanol: chloroform: ethyl acetate (7:3:0.5 %v/v/v), 
broad peak was observed. 
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¾ With methanol: chloroform: glacial acetic acid 
(9:0.9:0.1%v/v/v), a good symmetrical peak was observed.   
¾ With methanol: n-butanol (8:2 %v/v), the spot migrated with 
the solvent front. 
¾ With n-butanol: glacial acetic acid: ammonia 
(6:4:0.02%v/v/v), asymmetric peak was observed. 
            Out of all the mobile phases tried, methanol: chloroform: 
glacial acetic acid (9:0.9:0.1 %v/v/v) gave an acceptable peak with 
an Rf value of 0.73±0.02. Some of the chromatograms are shown in 
Fig. 18-20. 
4. Optimization of the mobile phase ratio  
 Standard stock solution was applied on to the pre-coated TLC 
plates and developed with different ratios of mobile phase such as  
7:2.9:0.1, 8:1.9:0.1 and 9:0.9:0.1 %v/v/v and the chromatograms were 
recorded. Tolterodine tartarate gave an acceptable peak with 
9:0.9:0.1 %v/v/v with an Rf value of 0.73 ±0.02.(Fig. 21-23). 
5. Fixed chromatographic parameters  
Stationary phase        :  Pre-coated silica gel 60F254 on Aluminium                    
  sheets 
Mobile phase         :   Methanol: Chloroform: Glacial acetic acid 
                                         (9:0.9:0.1 %v/v/v)  
Chamber Saturation   :  20 minutes 
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Migration Distance    :  85 mm 
Band width                :   6 mm 
Slit dimension          :   5 x 0.45 mm   
Source of Radiation   :   Deuterium lamp 
Scanning Wavelength :   282 nm 
Rf  value                     :    0.73 ± 0.02 
6.  Preparation of standard stock solution 
 Standard stock solution was prepared by weighing 10 mg of 
Tolterodine tartarate into a 10 ml standard flask and the volume was 
made upto 10 ml with methanol to get a concentration of 1000 µg/ml. 
From this, 3 ml of solution was pipetted into a 10 ml standard flask and 
made upto volume with methanol to get a concentration of 300 µg/ml. 
7. Preparation of standard graph  
            From the Stock solution, 1 to 5 µl was spotted on the TLC plate, 
followed by development and scanning the developed spots .The peak 
areas were recorded (Table : 17). Calibration graph was obtained by 
plotting the peak areas against the corresponding concentration of the 
standard solutions (Fig. 24-29). 
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Table  17  : Peak area values of Tolterodine tartarate 
             
8.  Analysis of formulation 
          20 tablets (Roliten, Ranbaxy Laboratories Limited., Mumbai), 
each containing 2 mg of Tolterodine tartarate were taken, weighed and 
a quantity equivalent to 10 mg of Tolterodine tartarate was taken in a 
10 ml standard flask and made upto volume with methanol, extracted 
by shaking and then filtered through a Whatman filter paper. From this 
solution, 3 ml was pipetted out into a 10 ml standard flask and made 
upto volume with methanol to get the concentration of 300 µg/ml .The 
formulation was assayed by spotting 3 µl onto the plate followed by 
development and scanning. The peak areas were recorded (Fig. 30) 
and the amount present was found (Table : 18) from the linear 
regression analysis and the equation as follows :  
 
Concentration (ng/spot) Peak area 
300 369.4 
600 959.8 
900 1518.5 
1200 1878.4 
1500 2560.4 
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y = α + βx 
α =     ( )( ) ( )( )( )22
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Where, x   =   concentration   
  y   =   absorbance 
  N  =   number of pairs of values  
Table  18 : Analysis of Formulation 
Amount(mg/tablet) 
Drug 
Labeled Found 
% Label claim* ±  
S.D 
Tolterodine 
tartarate 
2 1.99 99.6 ± 0.58 
* Mean of six determinations 
 
METHOD VALIDATION 
 The developed method was validated as per ICH guidelines in 
terms of linearity, accuracy, limit of detection, limit of quantification, 
precision and stability. 
1. Linearity and Range  
 Aliquots of standard solutions of Tolterodine tartarate were 
applied on the pre-coated silica gel 60F254 aluminium sheet. The plate 
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was dried, developed and analyzed .The linear regression data showed 
a good linear relationship over a concentration range of 300-1500 
ng/spot. The slope, intercept and correlation coefficient were found to 
be 1.626, 48.12 and 0.9993 respectively. 
2. Accuracy  
 The accuracy of the method was determined by conducting the 
recovery studies. Recovery studies were carried out at 50% and 100% 
levels. To 10mg equivalent of Tolterodine tartarate from tablet 
formulation, standard drug of Tolterodine tartarate was added at  
50% and 100% levels. The percentage recovery and %RSD were 
calculated. (Table : 19)       
Table  19 : Recovery studies 
%Recovery* %RSD  
Drug 50% 100% 50% 100% 
Tolterodine 
tartarate 
99.02 99.46 0.86 1.04 
* Mean of six determinations                                         
3. Precision  
           Precision of the method was determined by: 
¾ Intra-day Precision 
¾ Inter-day Precision 
¾ Repeatability 
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           Ö  Repeatability of Sample application 
 Ö Repeatability of Measurement 
Intra-day Precision  
          Intra-day Precision was found out by carrying out the analysis of 
the standard drug at two different concentrations- 900 and 1200 
ng/spot for four times on the same day. Each concentration was 
applied in triplicate and the %RSD was calculated. (Table : 20) 
Table 20 : Intra-day Precision 
 
Drug 
 
Concentration 
(ng/spot) 
 
Peak area 
 
%RSD* 
1524.6 
1512.8 
1513.3 
 
 
900 
1505.5 
 
 
0.52 
1860.2 
1862.7 
1826.9 
 
 
 
Tolterodine 
tartarate 
 
 
1200 
1841.2 
 
 
0.91 
* Mean of four determinations 
Inter-day precision  
           Inter-day Precision was determined by carrying out the analysis 
of the standard drug at two different concentrations – 900 and 1200 
ng/spot for two days and the %RSD was calculated. (Table : 21) 
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Table 21 : Inter-day Precision 
Drug Concentration (ng/spot) Days Peak area %RSD* 
1524.6 
1512.8 
1513.3 
 
1st 
1505.5 
 
0.52 
1534.0 
1522.0 
1530.3 
900 
 
2nd 
1530.3 
 
0.33 
1860.2 
1862.7 
1826.9 
 
1st 
1841.2 
 
0.91 
1862.7 
1864.2 
1864.2 
Tolterodine 
tartarate 
1200 
 
2nd 
1872.9 
 
0.23 
*Mean of four determinations 
 
Repeatability  
Repeatability of Sample application  
           Repeatability of sample application was determined by spotting 
900 and 1200 ng/spot of drug solution on a pre-coated TLC plate six 
times followed by development, scanning and the %RSD was 
calculated. (Table : 22) 
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Table 22 : Repeatability of Sample application 
 
Drug 
 
Concentration 
(ng/spot) 
 
Peak area 
 
%RSD* 
1553.7 
1546.2 
1530.5 
1563.0 
1558.6 
900 
1551.7 
0.91 
1865.4 
1861.2 
1871.1 
1802.0 
1822.2 
Tolterodine 
tartarate 
1200 
1863.7 
1.54 
*Mean of six determinations 
Repeatability of Measurement  
           Repeatability of measurement was determined by spotting 900 
and 1200ng/spot of drug solution on a pre-coated TLC plate and 
developed. The plate was then scanned six times without changing the 
position of the plate and the %RSD was calculated. (Table : 23) 
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Table  23  : Repeatability of Measurement 
 
Drug 
 
Concentration 
ng/spot 
 
Peak area 
 
%RSD* 
1530.5 
1535.7 
1544.0 
1539.2 
1531.9 
900 
1536.2 
1.57 
1877.9 
1875.1 
1869.2 
1879.3 
1873.0 
Tolterodine 
tartarate 
1200 
1870.4 
0.19 
* Mean of six determinations 
4.  Limit of Detection (LOD) and Limit of Quantification (LOQ): 
           LOD and LOQ were determined by applying decreasing amount 
of the drug in triplicate on the plate. The lowest concentration at which 
the peak is detected is called Limit of Detection and it was found to 
be 180 ng/spot. (Fig. 31) The lowest concentration at which the peak is 
quantified is called Limit of Quantification and it was found to be 300 
ng/spot. (Fig. 32). 
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5.  Stability Studies 
            When the developed chromatographic plate is exposed to the 
atmosphere, the analyte is likely to decompose. Hence, it is necessary 
to conduct the stability studies on the drug. Stability of Tolterodine 
tartarate on the plate was studied at different intervals and the peak 
areas were recorded. The developed plate was stable for three hours 
which was indicated by the reduction in the peak areas. 
(Table : 24) 
Table 24  : Stability Studies 
Drug Concentration 
ng/spot 
Time 
(hours) 
Peak area 
0 1867.7 
1/2 1836.1 
1 1821.2 
2 1801.0 
 
 
Tolterodine 
tartarate 
 
 
900 
3 1761.3 
 
Results and Discussion 
 The method developed was specific and there was no additional 
peaks observed for sample drug formulation. From the % RSD, it was 
observed that the method was precise. The content of Tolterodine 
Tartarate was found to be 1.99 mg/tab. The %recovery was found to be 
99.4± 1.04 at 100% level and 99.02±0.86 at 50%level. This indicated 
that the method was very accurate. Stability studies proved that the 
drug was stable for three hours after scanning. So, the method can be 
used for routine analysis of Tolterodine tartarate in its tablet dosage 
form. 
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Fig. 17 :   UV spectrum of Tolterodine tartarate on  TLC plate 
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SELECTION OF MOBILE PHASE 
Fig. 18:    Methanol : Chloroform : Ethyl acetate (7: 3: 0.5 %v/v/v) 
 
Fig. 19:   n-butanol : Glacial acetic acid : Ammonia   
( 6: 4: 0.02 %v/v/v) 
 
Fig. 20:Methanol: Chloroform: Glacial acetic acid ( 9: 0.9: 0.1 %v/v/v) 
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EFFECT OF RATIO OF MOBILE PHASE 
Fig. 21:  Methanol: Chloroform: Glacial acetic acid ( 7: 2.9: 0.1 %v/v/v) 
 
 Fig. 22:  Methanol: Chloroform: Glacial acetic acid ( 8: 1.9: 0.1 %v/v/v) 
 
Fig. 23:  Methanol: Chloroform: Glacial acetic acid ( 9: 0.9: 0.1 %v/v/v) 
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CHROMATOGRAM OF STANDARDS 
Fig. 24:    300 ng /spot 
 
Fig. 25:    600 ng /spot 
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Fig. 26:    900 ng /spot 
 
Fig. 27:   1200 ng /spot 
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Fig. 28:   1500 ng /spot 
 
Fig. 29:   Calibration graph of Tolterodine tartarate 
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Fig. 30:   Chromatogram of formulation 
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Fig. 31:   LOD 
 
Fig. 32:   LOQ 
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INTRODUCTION TO HPLC18-22 
       High performance liquid chromatography is a convenient separation 
technique used for wide types of samples, with exceptional resolving 
power, speed and nano molecular detection levels. This technique is 
based on the same modes of separation as that of classical 
chromatography i.e. adsorption, partition ion exchange and gel 
permeation, but it differs from column chromatography in the fact that the 
mobile phase is passed through the packed column under high pressure. 
           According to the phases involved, HPLC can be classified into 
several types which are as follows: 
a)  Partition chromatography       
 -  Normal phase chromatography       
-  Reverse phase chromatography      
b)   Liquid- solid chromatography or adsorption HPLC 
c)   Liquid- liquid chromatography or partition HPLC 
d)   Ion exchange chromatography 
e)   Size exclusion or gel permeation 
 f)   Ion- pair HPLC 
g)   Affinity HPLC 
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Parameters Used in Chromatographic Characterization 
Retention 
 The retention of a drug with a given packing material and eluent 
can be expressed as retention time or retention volume, but both of this 
are dependent on flow rate, column length and column diameter. The 
retention is best described as a column capacity ratio (k), which is 
independent of these factors. The column capacity ratio of a compound (A) 
is defined as  
o
oA
o
oA
A t
tt
V
VVk −=−=  
where, 
VA = Elution volume of A 
V0 = Elution volume of a non retained compound (void volume) 
Resolution  
The distance between any two adjacent peaks in a multi peak 
chromatogram is referred to as Resolution ‘Rs’ and is calculated as 
21
12
WW
)tt(2
R +
−=  
where, 
t1 and t2 are the retention times for the latest and the earliest eluting peak 
and W1 and W2, are the peak width at baseline. 
R>1 = Components completely separated 
R<1 = Components overlap 
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Capacity Factor (k´)  
 The retention of the analyte expressed as the number of void 
volumes of the system, needed for the peak to elute is called the capacity 
factor. The expression for k´ is 
0
0
t
tt
k r
−=′  
where, 
tr = retention time 
t0 = void volume 
Theoretical Plates (N)  
The number of theoretical plates generated on a column is a 
measure of its performance. The definition of N is  
⎟⎟⎠
⎞
⎜⎜⎝
⎛=
2/1W
r
t
t54.5N  
where, 
tr  = retention time 
tw 1/2  = is the peak width at half height 
‘N’ may also be calculated from the width along the baseline of the 
peak. This is accomplished by extending tangents from the two 
peak inflection points through the baseline. 
Separation factor (∝) 
This parameter is used to quantify the separation between adjacent 
peaks. Ideally, the peaks should not overlap, that is they should be 
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baseline-resolved. This condition is met for peaks of similar size when α > 
1.15. The separation factor is calculated as follows 
1
2
K
K
′
′=α  
where, 
the subscripts refer to the order of elution. 
∝ is always ≥ 1 
Asymmetry 
          The asymmetry is a tool for quickly determining how much if any, of 
an eluting peak profile deviates in shape from a normal distribution. The 
subscript ‘x’ refers to the percentage of peak height at which the 
asymmetry is determined. 
Eg: A10 (determined at 10% peak height) 
Peak asymmetry is given as:   
Ax=b/a 
where, 
b  = the distance between the perpendicular connecting the    
              baseline to peak maximum and the latest eluting   
    portion of the curve 
a  = the distance between the perpendicular connecting the  
              baseline to the peak maximum and the earliest eluting  
               portion of the curve.  
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QUANTITATIVE ANALYSIS 
Quantification involves the measurement of peak height or peak 
area. To determine the concentration of a compound, the peak area or 
height is plotted Vs the concentration of the substance. For well resolved 
peaks, both peak height and area are proportional to the concentration.  
Three different calibration methods used in quantitative analysis is external 
standard, internal standard and the standard addition method. 
 RETENTION IN RP-HPLC 
The reverse phase chromatography is based upon its polarity and 
experimental conditions such as mobile phase, column and temperature. 
Mobile Phase effects 
Retention (compound K value) can be preferably adjusted by 
changing mobile phase composition or solvent strength. In RPC, retention 
is less for stronger, less polar mobile phase. Solvent strength depends on 
the choice of organic solvent and its concentration in the mobile phase.  A 
retention range of 0.5 < k < 20 are allowable for samples to be separated 
using isocratic condition but 1 < k < 10 is generally preferred. 
a)  Choice of organic phase (%B) 
A mobile phase of 100% ACN is a stronger polar solvent, which 
may result in (k < 0.2), so a weaker mobile phase is required to retain the 
compound. This can be attained by decreasing the percentage of ACN 
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which in turn increases the retention time. When organic phase is 
decreased by 10% the k value increases 3 times approximately.  
b)  Mobile-phase strength 
Mobile phase strength in RPC depends upon both % B and the type 
of organic solvent. RPC solvent strength varies as water (weakest) < 
methanol < acetonitrile < ethanol < tetrahydrofuran < propanol < 
methylenechloride (strongest). Solvent strength increases as solvent 
polarity decreases.  
Column and Temperature effect 
An increase in temperature by 1oC will usually decrease values of k 
by 2% for non-ionic compounds, but it is not mostly used in RPC. For very 
hydrophobic samples it can be useful to operate at higher temperatures 
with a very strong mobile phase and very weak column. 
SELECTIVITY IN RP-HPLC  
Once overall sample retention is adjusted (0.5 < k < 20), it is 
necessary to change the band spacing or selectivity (α) of different bands. 
Three main variables used in RPC to change selectivity for neutral 
samples are mobile phase, column type and temperature. A small change 
in ‘α’ is adequate for separating many samples. 
 
Introduction To HPLC 
 
85
a)  Solvent- strength selectivity 
The best sample resolution will occur for a %B value where both 
pairs have the same resolution peak spacing can be explored while %B is 
varied for optimum sample retention (0.5 < k < 20). The use of solvent 
strength selectivity is limited mainly by the retention range of the sample. 
b)  Solvent Type selectivity 
A change in organic solvent type is often used to change peak 
spacing and improve resolution. The selection of RPC solvents for this 
purpose is guided by solvent properties that are believed to affect 
selectivity, acidity, basicity and diploarity.  
c)  Column Type selectivity 
A change in column type can produce useful changes in selectivity 
and overall sample retention. Retention is greater on the stronger C8 and 
phenyl column Vs the weaker cyano column.  
d)  Temperature Selectivity 
Values of k decreases at higher temperature for the RPC 
separation of neutral compounds. This is less effective for non-ionic 
compounds.  
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METHOD  DEVELOPMENT  AND  VALIDATION  FOR  THE 
ESTIMATION  OF  TOLTERODINE  TARTARATE  FROM  TABLET 
DOSAGE  FORM  BY  RP-HPLC. 
 
METHOD DEVELOPMENT 
 Shimadzu HPLC System – Class LC 10VP system with Photodiode 
array detector was used for the study. 
1. Selection of Stationary Phase 
Since Tolterodine tartarate is polar in nature, RP-HPLC method with 
C18 column was used for the development of the method. 
2. Selection of the Solvent 
The drug was dissolved in the mobile phase and suitably diluted 
and injected into the system. 
3. Selection of Detection Wavelength 
Good analytical results will be obtained only by careful selection of 
the wavelength used for detection. This choice requires knowledge of the 
UV spectra of the individual sample components. A UV spectrum of the 
drug was recorded and 282 nm was selected as the detection wavelength. 
(Fig. 33) 
4. Selection of the mobile phase 
Based on the solubility, different mobile phases were tried.          
(Fig. 34-36) 
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i) Water : methanol (50:50 %v/v) resulted in a broad peak with a Rt of 
4.11 
ii) Water (pH 3.4): methanol (50:50 %v/v) resulted in a broad peak 
with a Rt of 21.6 
iii) Water (pH 4.8): methanol (10:90 %v/v) resulted in a split peak with 
a Rt of 1.82 
iv) Water (pH 8.7): methanol (80:20 %v/v) resulted in a split peak with 
a Rt of 1.56 
v) Water: acetonitrile (50:50 %v/v) resulted in a broad peak with a Rt 
of 11.45 
vi) The drug did not elute in Potassium dihydrogen phosphate buffer  
(pH 9.5):methanol (30:70 %v/v)  
vii) 50 mM Sodium acetate buffer (pH 9.45): methanol (10:90 %v/v) 
resulted in a good symmetrical peak with a Rt of 2.43 
5.  Optimization of the Separation Conditions 
a)  Effect of Ionic strength 
Different ionic strengths of the Sodium acetate buffer such as 10 
mM, 25 mM, 50 mM and 100 mM were tried. The pH was adjusted to 9.45 
with 1% Triethylamine and mixed with methanol in the ratio 10:90 %v/v 
and their effect on the peak shape was observed. (Fig. 37-40) 
i) 10 mM Sodium acetate buffer: methanol resulted in tailing of the drug 
peak. 
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ii) 25 mM Sodium acetate buffer: methanol resulted in tailing of the drug 
peak. 
iii) 50 mM Sodium acetate buffer: methanol resulted in a good 
symmetrical peak. 
iv) 100 mM Sodium acetate buffer: methanol resulted in tailing of the 
drug peak. 
b) Effect of pH 
Different pH solutions of the 50 mM Sodium acetate buffer 
such as 4.3, 4.5, 8.5 and 9.45 were prepared and pH adjusted with 
1% triethylamine. A mobile phase consisting of 50 mM Sodium 
acetate buffer and methanol in the ratio 10:90 %v/v was used and 
their effect on the peak shape was observed. (Fig. 41-44) 
i) At pH 4.3, the drug peak resulted in giving a peak shoulder. 
ii) At pH 5, the drug peak resulted in giving a peak shoulder. 
iii) At pH 8.5, peak tailing was observed. 
iv) At pH 9.45, a good symmetrical peak was observed. 
c) Effect of Ratio 
50 mM Sodium acetate buffer was prepared and the pH was 
adjusted to 9.45 with 1% triethylamine. The mobile phase consisting of 50 
mM Sodium acetate buffer and methanol in various ratios such as 15:85, 
5:95, and 10:90 %v/v were prepared and the chromatograms were 
recorded. (Fig. 45-47)  
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i) In the ratio 5:95 %v/v, split peak was observed. 
ii) In the ratio 10: 90 %v/v, a good symmetrical peak was observed.                             
iii) In the ratio 15:85 %v/v, tailing of the drug peak was observed. 
d)  Effect of Flow rate 
 Keeping the ionic strength, pH of the buffer and the ratio of the 
mobile phase fixed, the chromatograms were recorded at different flow 
rates such as 0.8, 1.0 and 1.2 ml/min. (Fig. 48-50) 
i) At 0.8 ml/min, the retention time got shifted to 3.1min. 
ii) At 1.2 ml/min, the retention time got shifted to 1.9 min. 
iii) At 1.0 ml/min, a good symmetrical peak was observed with a Rt of 2.43 
min. 
7.  Fixed Chromatographic Conditions 
 Stationary Phase           :  Gemini, Phenomenex C18 (150 x 4.6 mm, 5 µ) 
 Mobile Phase                :  50 mM Sodium acetate Buffer: Methanol 
 Ratio                             :  10: 90 %v/v 
 Flow rate                       :  1.0 ml/min 
 Detection Wavelength   :  282 nm 
8.  Preparation of the Stock Solution 
         10 mg of Tolterodine tartarate was weighed accurately and 
transferred into a 10 ml standard flask, dissolved in the mobile phase to 
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get a concentration of 1000 µg/ml. This stock solution was suitably diluted 
with the mobile phase to get a concentration of 100 µg/ml. 
9.  Preparation of Standard solution                                                 
           From the Stock solution 0.2, 0.4, 0.6, 0.8,1.0 ml were transferred 
into a series of 10 ml standard flasks and the volume was made upto 10 
ml with the mobile phase to get concentrations ranging from 2 to 10 µg/ml. 
Chromatograms of these solutions were obtained by injecting 20 µl of each 
standard solution into the system and the peak areas were recorded. The 
peak areas were plotted against the corresponding concentrations (Table : 
25), calibration graph was constructed and the slope, intercept and 
correlation coefficient was determined. The standard solutions were found 
to be linear in the range of 2 to 10 µg/ml with a correlation coefficient of 
0.9991. (Fig. 51-56) 
 
Table : 25   Peak area values of Tolterodine tartarate 
 
  
 
 
 
 
 
Concentration (µg/ml) Peak Area 
2 13455 
4 28214 
6 40675 
8 52915 
10 64944 
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10.  Analysis of the Formulation:  
           20 tablets (Roliten, Ranbaxy Laboratories Limited, India) each 
containing 2 mg of Tolterodine tartarate were weighed and the average 
weight was calculated. A quantity equivalent to 10 mg of Tolterodine 
tartarate was transferred into a 10 ml standard flask and extracted with the 
mobile phase by shaking for 30 minutes. The solution was filtered through 
a Whatman filter paper and suitably diluted with the mobile phase to get a 
concentration of 100 µg/ml. From this, suitable aliquots of concentration 6 
and 8 µg/ml were prepared. A chromatogram of these solutions were 
obtained by injecting 20 µl of each sample solutions into the system (Fig. 
57)The peak areas were recorded and the amount of Tolterodine tartarate 
in the formulation was determined.(Table : 26) 
 
Table : 26 Analysis of Formulation 
Amount (mg/tablet)  
Drug Labeled Found 
 
%Label 
claim*± S.D 
Tolterodine 
tartarate 2 1.99 99.89 ± 1.33 
              *Mean of six determinations 
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METHOD VALIDATION 
 The developed method was validated as per ICH guidelines and the 
standard deviation and relative standard deviation were calculated using 
the formula: 
S.D = 
( )
1
2
−
−∑
n
xx
 
% RSD = 
x
DSx ..100  
                 Where, S.D. = standard deviation 
                           R.S.D = relative standard deviation  
1. Specificity 
 There were no additional peaks found with the alteration in the 
experimental conditions such as pH, flow rate, ratio etc., which revealed 
that the developed method was specific for the drug. 
2.  Linearity and Range 
From the Stock solution, 0.2 to 1.0 ml were transferred into a series 
of 10 ml standard flasks and the solutions were made upto volume with the 
mobile phase to get concentrations ranging from 2 to 10 µg/ml .Calibration 
graph was prepared by plotting peak area Vs concentration .Tolterodine 
tartarate showed good linear relationship in the concentration range 2-10 
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µg/ml and the slope, intercept and correlation coefficient was found to be 
6383.95, 1736.9 and 0.9991 respectively.  
3.  Precision 
 Precision of the method was determined by: 
a. Intra-day precision   
b. Inter-day precision   
c. Repeatability of Injection 
a. Intra-day precision  
 Intra-day precision was determined by injecting three solutions of 
the same concentration (4 µg/ml) for three times on the same day and the 
response for each injection was measured .Peak areas were noted and 
%RSD was calculated. (Table : 27) 
Table : 27 Intra-day precision 
Drug Concentration    (µg/ml) Peak Area %RSD* 
28507 
28040 Tolterodine   tartarate 4 
28846 
1.47 
* Mean of three determinations 
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b. Inter-day precision  
 Inter-day precision was determined by injecting a concentration of 
the standard solution (4 µg/ml) for three days and %RSD was calculated. 
(Table : 28) 
Table : 28  Inter-day precision 
Drug Concentration(µg/ml) Days Peak Area %RSD* 
28507 
28040 I 
28846 
1.47 
28475 
28496 II 
28366 
0.52 
28183 
28033 
Tolterodine    
tartarate 
 
4 
III 
28532 
0.94 
*Mean of three determinations 
c. Repeatability of Injection  
 The standard solution of Tolterodine tartarate of concentration 4 
µg/ml was injected three times and the response for each injection was 
recorded and the %RSD was calculated. (Table  : 29) 
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Table  : 29 Repeatability of Injection 
Drug Concentration (µg/ml) Peak Area %RSD* 
28428 
28735 
Tolterodine 
tartarate 4 
28465 
0.63 
*Mean of three determinations 
4.  Accuracy 
 The accuracy of the developed method was determined by 
conducting the recovery studies at 100% level .To the pre-analyzed 
formulation, standard drug of Tolterodine tartarate was added at 100% 
concentration level .The recovery procedure was repeated three times and 
%recovery was calculated. (Table : 30) 
Table  : 30 Recovery Studies 
Drug %Recovery* %RSD 
Tolterodine 
Tartarate 103.37 0.52 
* Mean of six determinations 
5.  Limit of Detection and Limit of Quantification 
 LOD and LOQ of the developed method were determined by 
injecting low concentrations of the standard solution under optimized 
chromatographic conditions. LOD was found to be 10 ng/ml and LOQ was 
found to be 0.1 µg/ml. (Fig. 58, 59) 
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6.  Stability 
 Stability of the analyte in stock solution was checked under room 
temperature and refrigeration conditions. The stored solution was found to 
be stable under room temperature for 24 hrs and under refrigeration 
conditions for 48 hrs. (Fig. 60, 61) 
7.  System suitability studies 
System suitability studies were conducted as per USP 
specifications for the developed method and Column efficiency (N), 
Capacity factor (k´) and tailing factor were established. (Table : 31) 
Table  : 31 System suitability studies 
Column efficiency (N) 4560 
Tailing factor 1.36 
Capacity factor (k´) 1.21 
Results and Discussion 
          The results obtained by this method are precise and reproducible for 
the estimation of Tolterodine tartarate in its tablet dosage form. The 
percentage recovery was found to be 103% ± 0.52 with low level of S.D. 
which indicates the accuracy of the method. The content of Tolterodine 
tartarate in the tablet dosage form was found to be 1.99 mg/tab. Hence, 
the developed method can be used for the routine analysis of Tolterodine 
tartarate in the tablet dosage form. 
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Fig.33 :  U.V. Spectra of Tolterodine tartarate in mobile phase 
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SELECTION OF MOBILE PHASE 
Fig. 34:   Water : Acetonitrile ( 50:50 %v/v) 
 
Fig. 35:   Water : Methanol (50:50 % v/v) 
 
Fig. 36:  50 mM sodium acetate buffer (pH 9.45):methanol(10:90 %v/v) 
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EFFECT OF IONIC STRENGTH 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
Fig. 37:  10 mM Sodium Acetate 
buffer: methanol  
(10:90 %v/v)
Fig. 38:  25 mM Sodium Acetate 
buffer: methanol (10:90 %v/v) 
Fig.  39 :   50 mM Sodium 
Acetate buffer : methanol 
(10:90 %v/v) 
Fig. 40 :  100 mM Sodium 
Acetate buffer : methanol 
(10:90 %v/v) 
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EFFECT OF pH 
 
 
 
 
 
 
 
       Fig. 41:  pH 4.3                   Fig. 42: pH 5 
 
 
 
 
 
 
 
 
              Fig. 43:   pH 8.5            Fig. 44: pH 9.45 
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EFFECT OF RATIO 
Fig. 45:    5:95  %v/v 
 
Fig. 46:   10:90 % v/v    
 
` 
 
 
 
 
Fig. 47:   15:85  %v/v 
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  EFFECT OF FLOW RATE 
Fig. 48:  0.8 ml/ min 
 
Fig. 49:  1.0  ml/ min 
 
 
 
 
 
 
 
 
 
 
Fig. 50:  1.2  ml/min 
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CHROMATOGRAM OF STANDARDS 
Fig. 51:   2µg/ml    Fig. 52:  4 µg/ml 
 
 
 
 
 
 
Fig. 53:   6 µg/ml             Fig. 54:   8 µg/ml 
 
 
 
 
 
Fig. 55 : 10 µg/ml 
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Fig.56 :   Calibration graph of Tolterodine  tartarate 
 
Fig. 57 :    Chromatogram of formulation 
 
 
 
 
 
 
 
 
 
 
Experimental Section 
 
105
Fig. 58:   LOD 
 
 
 
 
 
 
 
 
 
Fig. 59:    LOQ 
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   Fig .  60:  Stability - Room temperature 
 
Fig. 61:   Stability- refrigeration  condition 
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